Learn More
Apexbio Technology LLC GSK2656157 1337532-29-2 50mg

Supplier: Apexbio Technology LLC B217550
GSK2656157 (CAS 1337532-29-2) is a highly selective inhibitor of protein kinase R-like endoplasmic reticulum kinase (PERK) demonstrating an IC50 of 0 9 nM In kinase selectivity assays involving 300 kinases GSK2656157 displays marked specificity for PERK In cellular studies using BxPC3 pancreatic cancer cells this compound blocks PERK signaling reducing phosphorylation of downstream targets including eIF2 ATF4 and CHOP and subsequently suppressing protein synthesis In animal models bearing human tumor xenografts including pancreatic (BxPC3 HPAC Capan2) and multiple myeloma (NCI-H929) oral administration of GSK2656157 results in dose-dependent inhibition of tumor growth with notable sensitivity in Capan2 tumors
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.